| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10920482 | Radiotherapy and Oncology | 2005 | 11 Pages |
Abstract
As GTV and CTV for BT change significantly during treatment, time frame for assessment of GTV and CTV for BT is specified in this report: at time of diagnosis GTVD, CTVD and at time of BT GTVB, CTVB. Furthermore, CTV for BT is defined related to risk for recurrence: high risk CTV and intermediate risk CTV. Beside verbal descriptions detailed examples are given, partly in form of schematic drawings.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Christine Haie-Meder, Richard Pötter, Erik Van Limbergen, Edith Briot, Marisol De Brabandere, Johannes Dimopoulos, Isabelle Dumas, Taran Paulsen Hellebust, Christian Kirisits, Stefan Lang, Sabine Muschitz, Juliana Nevinson, An Nulens, Peter Petrow,